BTK inhibitor
US10662174B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2017 |
| Grant date | May 26, 2020 |
| Priority date | — |
| Expiry date | Jul 14, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C13/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.